The Overprovision of Infectious Disease Medicine

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.

Original languageEnglish
Pages (from-to)61-66
Number of pages5
JournalEconomics Letters
Volume80
Issue number1
DOIs
Publication statusPublished - Jul 2003

Keywords

  • epidemics
  • externalities
  • drug provision
  • VACCINATION
  • PRIVATE

Cite this

The Overprovision of Infectious Disease Medicine. / Skatun, John Douglas Fordyce.

In: Economics Letters, Vol. 80, No. 1, 07.2003, p. 61-66.

Research output: Contribution to journalArticle

@article{da8ae4d3e71e4c2c95edd0d64e64afa9,
title = "The Overprovision of Infectious Disease Medicine",
abstract = "This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.",
keywords = "epidemics, externalities, drug provision, VACCINATION, PRIVATE",
author = "Skatun, {John Douglas Fordyce}",
year = "2003",
month = "7",
doi = "10.1016/S0165-1765(03)00065-X",
language = "English",
volume = "80",
pages = "61--66",
journal = "Economics Letters",
issn = "0165-1765",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - The Overprovision of Infectious Disease Medicine

AU - Skatun, John Douglas Fordyce

PY - 2003/7

Y1 - 2003/7

N2 - This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.

AB - This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.

KW - epidemics

KW - externalities

KW - drug provision

KW - VACCINATION

KW - PRIVATE

U2 - 10.1016/S0165-1765(03)00065-X

DO - 10.1016/S0165-1765(03)00065-X

M3 - Article

VL - 80

SP - 61

EP - 66

JO - Economics Letters

JF - Economics Letters

SN - 0165-1765

IS - 1

ER -